ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Tyra Biosciences Inc

Tyra Biosciences Inc (TYRA)

15.90
0.03
( 0.19% )
Updated: 10:54:36

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
15.90
Bid
15.87
Ask
16.02
Volume
25,098
15.58 Day's Range 16.09
10.6004 52 Week Range 29.60
Market Cap
Previous Close
15.87
Open
15.87
Last Trade
10
@
15.945
Last Trade Time
10:54:40
Financial Volume
$ 395,291
VWAP
15.7499
Average Volume (3m)
335,225
Shares Outstanding
50,602,991
Dividend Yield
-
PE Ratio
-11.58
Earnings Per Share (EPS)
-1.37
Revenue
-
Net Profit
-69.13M

About Tyra Biosciences Inc

Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Tyra Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TYRA. The last closing price for Tyra Biosciences was $15.87. Over the last year, Tyra Biosciences shares have traded in a share price range of $ 10.6004 to $ 29.60.

Tyra Biosciences currently has 50,602,991 shares outstanding. The market capitalization of Tyra Biosciences is $803.07 million. Tyra Biosciences has a price to earnings ratio (PE ratio) of -11.58.

TYRA Latest News

Tyra Biosciences to Present at Upcoming Investor Conferences

Tyra Biosciences to Present at Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., Nov. 13, 2024 CARLSBAD, Calif., Nov. 13, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a...

Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights

Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights PR Newswire CARLSBAD, Calif., Nov. 7, 2024 - Reported positive interim clinical proof-of-concept results for TYRA-300...

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Pediatric Achondroplasia (BEACH301)

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Pediatric Achondroplasia (BEACH301) PR Newswire CARLSBAD, Calif., Oct. 28, 2024 – TYRA-300 is the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.69-4.1591320072316.5916.6715.0436131315.73171285CS
4-12.96-44.906444906428.8629.615.0461667018.24321334CS
12-5.62-26.115241635721.5229.615.0433522520.28883075CS
26-2.77-14.836636314918.6729.615.0423469319.96642984CS
524.6941.837644959911.2129.610.600417811718.75137935CS
156-7.68-32.569974554723.5829.64.9311150315.7658068CS
260-14-46.822742474929.931.364.9312217016.32665521CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WORXSCWorx Corporation
$ 1.94
(97.96%)
99.02M
CRNCCerence Inc
$ 5.30
(87.94%)
23.7M
SKKSKK Holdings Limited
$ 7.32
(60.53%)
5.65M
IBGInnovation Beverage Group Limited
$ 1.26
(59.25%)
4.2M
SURGSurgePays Inc
$ 2.115
(44.86%)
11.62M
PYXSPyxis Oncology Inc
$ 2.08
(-45.55%)
8.22M
KURAKura Oncology Inc
$ 9.9613
(-37.39%)
6.84M
SHOTWSafety Shot Inc
$ 0.1001
(-33.27%)
2.5k
BLRXBioLineRx Ltd
$ 0.37
(-32.13%)
4.96M
TMTCTMT Acquisition Corporation
$ 4.66
(-27.64%)
12.11k
CDTConduit Pharmaceuticals Inc
$ 0.1156
(25.24%)
463.61M
NVDANVIDIA Corporation
$ 143.17
(-1.86%)
180.58M
AKTSAkoustis Technologies Inc
$ 0.1049
(20.44%)
177.49M
ELABElevai Labs Inc
$ 0.0203
(-5.14%)
115.33M
WORXSCWorx Corporation
$ 1.9353
(97.48%)
99.94M